
Book · Will Alaynick
Venture Capital For Life Scientists
A foundational guide for life scientists seeking to understand the venture capital landscape, its key concepts, and the transition from research to company building.
Buy on Amazon →Resources
Resources created by our team to help life science founders navigate venture capital and protect what they build.
For founders

Book · Will Alaynick
A foundational guide for life scientists seeking to understand the venture capital landscape, its key concepts, and the transition from research to company building.
Buy on Amazon →
IP management platform
One place to manage patents, trademarks, agreements, deadlines, and filings.
Notable IP was created to support Phase Two Ventures portfolio companies and is now available to anyone. Its AI-powered workspace helps startups and counsel replace scattered spreadsheets with a clear, shared view of their intellectual property.
Visit Notable IP →Portfolio support
Phase Two Ventures is a member of the Anthropic VC Partner Program.
Portfolio companies can access Claude API credits at partner-tier levels, priority rate limits, and invitations to Anthropic founder events.
These benefits help technical teams explore, build, and scale AI-enabled products with direct support from the Anthropic startup ecosystem.
Events
We host regular gatherings where founders, scientists, operators, and investors can exchange ideas, build relationships, and explore what is next in life science tools and AI × Bio.
June 2026
A private gathering for founders and experts to connect and discuss advances at the intersection of artificial intelligence and biology.
View event →December 2025
Our portfolio community came together to reflect on the fund's progress and the companies building the next generation of life science tools.
View event →June 2025
More than 75 founders, investors, scientists, operators, and community connectors gathered to strengthen San Diego's life science ecosystem.
View event →We back pre-seed and seed founders in life science tools, platform technologies, and AI x Bio.